Kodu・Aktsiate loetelu・Coloplast A-S (Class B)
Search

Coloplast A-S (Class B)

Avatud

419.7 3.86

Neutraalne

Hinna uuendus 27. juuli 2026, 14:54 UTC

OstaMüü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

404.1

Max

417.7

Põhinäitajad

By Trading Economics

Sissetulek

-2.4B

-971M

Müük

41M

7.1B

P/E

Sektori keskmine

44.116

62.58

Aktsiakasum

-0.16

Dividenditootlus

5.5

Kasumimarginaal

-13.707

Töötajad

17,083

EBITDA

2.8B

5.1B

Soovitused

By TipRanks

Soovitused

Neutraalne

12 kuu keskmine prognoos

+11.86% upside

Dividendid

By Acuity

Dividenditootlus

Sektori keskmine

5.50%

2.19%

Turustatistika

By TradingEconomics

Turukapital

5B

95B

Eelmine avamishind

415.84

Eelmine sulgemishind

419.7

Coloplast A-S (Class B) Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

26. juuli 2026, 23:56 UTC

Cryptocurrency values rise as global equity markets approach $166 trillion amid mixed sentiment and geopolitical uncertainties.

Loe

26. juuli 2026, 23:56 UTC

"Ethereum and Bitcoin rise amid mixed market sentiment as Japan shifts to expansionary fiscal policy and key economic data looms."

Loe

26. juuli 2026, 23:56 UTC

"Ethereum Rises 4.2% Amidst Strong Global Equity Markets and Upcoming Key Economic Data Releases."

Loe

26. juuli 2026, 23:56 UTC

Cryptocurrency gains amid cautious investor sentiment in global equities as markets brace for key economic data and Fed interest rate decision.

Loe

26. juuli 2026, 23:52 UTC

Australia's RBA Trimmed Mean CPI Release on July 29, 2026, Expected to Impact Monetary Policy Amid Rising Trade Tensions and Cost-of-Living Concerns.

Loe

26. juuli 2026, 23:52 UTC

Australia's Inflation Rate YoY Data Set for Release on July 29, 2026, with Forecasted Increase to 4.1%, Impacting Monetary Policy and Market Sentiment.

Loe

26. juuli 2026, 23:51 UTC

Correlated Moves

EUR/CAD shows a slight increase in after-hours trading, reflecting volatility and aligning with a similar uptick in EUR/USD amid comparable macroeconomic factors.

Loe

26. juuli 2026, 23:51 UTC

EUR/SEK shows notable weakness in after-hours trading, declining since Friday's close and reaching a session low amid unusual downward pressure.

Loe

26. juuli 2026, 23:51 UTC

Macro News
Correlated Moves

Bitcoin prices have risen to $65,392, reflecting optimism amid speculation of reaching $180,000. Trade tensions could impact global markets, including cryptocurrencies.

Loe

26. juuli 2026, 23:41 UTC

GBP/CAD advances slightly in after-hours trading, positioned near the lower end of its one-month range. No specific news was identified for the move.

Loe

26. juuli 2026, 23:41 UTC

Upcoming U.S. Employment Cost Index report on July 31 to reveal key wage growth data amid rising inflation and consumer concerns over grocery prices.

Loe

26. juuli 2026, 23:41 UTC

Employment Cost Index for Q2 2026 set to rise by 0.8%, signaling potential implications for inflation and Federal Reserve interest rate decisions.

Loe

26. juuli 2026, 23:41 UTC

U.S. Employment Cost Index Benefits Data Set for Release on July 31, 2026, Amid Global Labor Market Dynamics and Inflation Concerns.

Loe

26. juuli 2026, 23:41 UTC

Canada's preliminary monthly GDP report on July 31, 2026, is anticipated to reveal growth amid mixed economic signals and external risks.

Loe

26. juuli 2026, 23:23 UTC

Upcoming PCE Price Index Release on July 30, 2026, Expected to Reflect Consumer Inflation Amid Rising Grocery Prices and Economic Pressures.

Loe

26. juuli 2026, 23:23 UTC

U.S. PCE Price Index Expected to Rise 0.4% in June Amid Ongoing Inflation Concerns and Consumer Behavior Shifts

Loe

26. juuli 2026, 23:23 UTC

U.S. Personal Spending MoM Data Release on July 30, 2026 Expected to Show 0.4% Growth Amid Rising Grocery Prices and Changing Consumer Habits.

Loe

26. juuli 2026, 23:23 UTC

Core PCE Price Index MoM for June 2026 set to release on July 30, with a modest forecasted increase of 0.1%, as markets remain cautiously optimistic amid mixed equity performance and Fed policy discussions.

Loe

26. juuli 2026, 23:23 UTC

US Personal Income MoM Data Release on July 30, 2026 Expected to Show Modest 0.3% Increase Amid Mixed Economic Signals

Loe

26. juuli 2026, 23:23 UTC

U.S. GDP Price Index Forecasted to Rise 3.7% Amid Inflation Concerns Ahead of July Release

Loe

26. juuli 2026, 23:23 UTC

U.S. Q2 2026 GDP Growth Rate Release Forecasts 2.3% Amid Cautious Market Sentiment and Rising Consumer Prices

Loe

26. juuli 2026, 23:23 UTC

South Korea's July export growth expected to remain strong at 70.9% YoY amid market volatility and global uncertainties, with a report due August 1, 2026.

Loe

26. juuli 2026, 23:13 UTC

South Africa's upcoming balance of trade data on July 31, 2026, is crucial as it follows a surprising May deficit amid rising imports and declining exports.

Loe

26. juuli 2026, 23:13 UTC

S&P/Case-Shiller Home Price Index Expected to Show Modest 0.8% YoY Growth Amid Cooling U.S. Housing Market and High Inflation Concerns

Loe

26. juuli 2026, 23:11 UTC

Correlated Moves
News

Ethereum is rising during Sunday’s trading session, gaining alongside Bitcoin amid strong market activity and global developments influencing investor sentiment.

Loe

26. juuli 2026, 23:11 UTC

Correlated Moves
News

Ethereum is advancing during Sunday’s session, supported by Bitcoin's upward movement. The asset is trading well above recent averages amid strong market activity.

Loe

26. juuli 2026, 23:02 UTC

After-market trading for SGD/CHF shows an upward trend, gaining since Friday's close. It is currently 1.09% above its 20-day moving average.

Loe

26. juuli 2026, 23:01 UTC

GBP/CHF moved higher during after-market hours, reflecting strong momentum near the upper end of its one-month range. No specific news was identified.

Loe

26. juuli 2026, 23:01 UTC

Correlated Moves

GBP/HKD is trading higher in after-market hours, reflecting a cumulative return that peaked at 0.30%. The pair shows unusual strength amid recent EUR/USD gains.

Loe

26. juuli 2026, 23:01 UTC

Brazil's Unemployment Rate Release on July 30 Expected to Show Continued Improvement Amid Economic Optimism and External Challenges.

Loe

Coloplast A-S (Class B) Prognoos

Hinnasiht

By TipRanks

11.86% tõus

12 kuu keskmine prognoos

Keskmine 901.38 DKK  11.86%

Kõrge 1,056 DKK

Madal 720 DKK

Põhineb 8 Wall Streeti analüütiku instrumendi Coloplast A-S (Class B) 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

8 ratings

2

Osta

4

Hoia

2

Müü

Põhineb 8 analüütiku instrumendi Coloplast A-S (Class B) aktsia reitingul - viimase 3 kuu andmed.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat